Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05183971
Other study ID # UW 20-746
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2022
Est. completion date September 30, 2036

Study information

Verified date May 2023
Source The University of Hong Kong
Contact Karlen Ka Pui Law, M. Phil
Phone 852-29740531
Email karlenhk@connect.com.hk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Proprioceptive deficits in degenerative cervical myelopathy (DCM) is a progressive neurological deficits in somatosensory and motor function which affects the body balance and motor control. DCM usually presents with body incoordination, hand clumsiness and gait disturbance associated with proprioceptive dysfunction that hinders the physical performance and functions. In this study, a non-invasive assessment protocol on proprioception will be developed for detecting subtle proprioceptive deficits at the early stage of disease through simple Physical Performance Tests for population older than 45. By adopting the physical performance tests as the diagnostic predictors of DCM, we aim to avoid the development of devastating consequences and disabilities.


Description:

DCM is a chronic insidious disease, one of the most disabling orthopaedic conditions, which involves compression of the spinal cord by the surrounding structures in cervical spinal region. It characterizes with progressive neurological deficits in body coordination, hand clumsiness and gait disturbance as the preliminary symptom which may cause by proprioceptive dysfunction . Physical performance and function hinder patients' hand clumsiness, gait disturbance and body imbalance. The incoordination between body, upper limbs and lower limbs will be resulted from proprioceptive deficits caused by spinal cord compression. By adopting the Proprioceptive Functional Analysis System (PFAS), proprioceptive deficits over the core body joints and peripheral joints could be tested during Activity of Daily Living (ADL) with reference to normal subjects' performance. All subjects will be tested by the PFAS and Physical Performance Tests. The idea of regional proprioceptive deficit will be incorporated in the assessment protocol for DCM to facilitates a breakthrough from the traditional DCM functional evaluation. In developing a non-invasive assessment protocol to assess proprioceptive deficit, we aim to detect subtle proprioceptive deficit from the tests, especially at the very early stage of disease. We target to demonstrate the validity of Physical Performance Tests are evenly high as that of the advanced technology, PFAS. Consequently, by adopting the valid Physical Performance Tests in health screening scheme for population older than 45 within the community can serve as an early diagnostic parameter of DCM and avoid delayed treatment leading to devastating consequences and disabilities.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date September 30, 2036
Est. primary completion date September 30, 2035
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Chinese - Aged 50 or above - With radiological evidence of degenerative cervical myelopathy, both symptomatic and asymptomatic - Nurick grade less than 3 Exclusion Criteria: - Non-Chinese ethnicity - Aged under 50 - without any radiological proof of cervical myelopathy - Active problems of tuberculosis spine, lumbar spinal diseases, and other problems causing pain or deformities over the limbs that may affect their balance and movement - Presents with extra-pyramidal or other disorders involving the cerebellum or frontal lobe of the cerebrum leading to poor balance and gait disturbance - Previous spinal operation with residual disturbance in balance or gait - Non-communicable patients with insufficient cognitive ability to express their symptoms clearly - Non-walker - Blind or deaf

Study Design


Intervention

Other:
Proprioceptive Functional Analysis System
Proprioceptive testing and Physical Performance Tests

Locations

Country Name City State
Hong Kong The Duchess of Kent Children's Hospital at Sandy Bay Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Japanese Orthopaedics Association Scoring System for Cervical Myelopathy (mJOA) mJOA is a self-reported functional questionnaire on disease severity through assessing 4 domains:
Upper Limb Function
Lower Limb Function
Sensory Function
Bladder Function
mJOA has a total score of 17 and it categories DCM patient into different severity as below:
Mild >= 15
Moderate = 12-14
Severe < 12
15 years
Secondary Proprioceptive Deficits - Speed Test Proprioceptive deficits hinder the limb coordination, especially the fine finger dexterity, reciprocal walking and stepping. Thus, incoordination over the lower and upper limbs will then be resulted and which alters the speed and integrity of the performance in the Physical Performance Tests validated for DCM.
In the physical performance tests, it has divided into 2 separate sections, the "Speed Test" will be recorded for in terms of the "Time required to complete" the standardized test process in seconds
15 years
Secondary Proprioceptive Deficits - Time Limited Test Time Limited Test of physical performance test will be assessed and data will be recorded in terms of "Total number of repetitions completed" within strictly fixed time frame 15 years
See also
  Status Clinical Trial Phase
Completed NCT03695848 - Prognostic Value of DTI and fMRI of Cervical Myelopathy
Terminated NCT00974623 - Bone Graft Materials Observational Registry N/A
Enrolling by invitation NCT04381663 - CSS-Assessing the Course of Degenerative Cervical Spinal Stenosis Using Functional Outcomes
Recruiting NCT05163639 - Spinal Cord Associative Plasticity Study Early Phase 1
Completed NCT02125981 - The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy Phase 3
Withdrawn NCT04315090 - Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion
Not yet recruiting NCT05099627 - Machine Learning Diagnosis and Prediction for Cervical Myelopathy
Completed NCT04173923 - Long Term Follow-up of Cervical Myelopathy Inpatients Treated With Integrated Complementary and Alternative Medicine
Enrolling by invitation NCT05066711 - NuVasive® ACP System Study
Enrolling by invitation NCT04770571 - Posterior Cervical Fixation Study
Terminated NCT02758899 - Diabetes and Glycosylation in Cervical Spondylosis
Completed NCT04962256 - ERAS in Posterior Approach of Cervical Spine Operation
Completed NCT04320043 - Adjacent Segment Disease After Anterior Cervical Decompression Surgery
Recruiting NCT05446259 - Degenerative Cervical Myelopathy Repository
Completed NCT03304236 - Motion Analysis of the Myelopathy Hand: New Insight Into the Classical Sign
Completed NCT02842775 - Clinical Evaluation and Rehabilitation System for Dynamic Balance Control in Cervical Myelopathy Patients N/A
Completed NCT01027546 - Effect of Tranexamic Acid on Reducing Postoperative Blood Loss in Cervical Laminoplasty N/A
Recruiting NCT04968639 - The Characteristic of Axial Pain and EEG Analysis of Patients After Laminoplasty
Recruiting NCT03950349 - FUSION EVALUATION AFTER ANTERIOR CERVICAL DISCECTOMY AND FUSION WITH STAND ALONE LOCKING CAGE WITH BLADE HRCC®
Enrolling by invitation NCT05762055 - Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology N/A